Skip to main content
PharmAbcine Inc. logo

PharmAbcine Inc. — Investor Relations & Filings

Ticker · 208340 ISIN · KR7208340000 KO Manufacturing
Open in API
Filings indexed 461 across all filing types
Latest filing 2020-12-15 Regulatory Filings
Country KR South Korea
Listing KO 208340

About PharmAbcine Inc.

http://pharmabcine.com/

PharmAbcine Inc. is a clinical-stage biotechnology company specializing in the development of fully human therapeutic monoclonal antibodies (mAbs). The company focuses on creating innovative treatments for diseases with high unmet medical needs, primarily in oncology, neovascular eye diseases, and other inflammatory and vascular disorders. Utilizing its proprietary human antibody library and discovery technologies, PharmAbcine advances a pipeline of next-generation IgG-based therapeutics. The company's mission is to contribute to human health by providing novel antibody-based drugs to patients.

Recent filings

Filing Released Lang Actions
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the suspension of share registration (shareholder register closure) for the purpose of determining shareholders eligible to vote at the 13th Annual General Meeting. It does not contain the full report or proxy materials themselves, but rather serves as a formal regulatory notice of a corporate action. Given the nature of the announcement as a regulatory filing regarding shareholder rights and meeting preparation, it fits best under the RNS category.
2020-12-15 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a short announcement titled '임시주주총회결과' (Extraordinary General Meeting Results) dated 2020-12-01. It details the outcome of a specific agenda item (approval of deficit compensation) voted on during the meeting. This falls under the category of Declaration of Voting Results.
2020-12-01 Korean
분기보고서 (2020.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company 'PharmAbcine' (주식회사 파멥신) for the 3rd quarter of 2020. It contains detailed financial information, business operations, capital changes, and management discussions, which are characteristic of a formal quarterly financial report. It is not an announcement of a report, but the report itself, and it contains substantive financial data. 9M 2020
2020-11-13 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of Extraordinary General Meeting' (주주총회소집공고) issued by PharmAbcine. It details the meeting date, location, agenda items (specifically the resolution for capital reserve deficit compensation), and provides management information, including board activity and business overview. This document is a standard proxy statement/notice for a shareholder meeting, which falls under the 'Proxy Solicitation & Information Statement' category.
2020-11-13 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Reference Document' (참고서류) for a shareholder meeting, specifically detailing the solicitation of proxy votes (위임권유) for an Extraordinary General Meeting of Shareholders. It includes information about the solicitor, the purpose of the meeting (capital reserve deficit compensation), and instructions for proxy voting. This aligns perfectly with the definition of a Proxy Solicitation & Information Statement (PSI).
2020-11-13 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Proxy Solicitation' (참고서류) filed by PharmAbcine. It contains information regarding the solicitation of proxies for a shareholder meeting, including details about the solicitor, the purpose of the meeting (capital reserve usage for deficit compensation), and instructions for shareholders to delegate their voting rights. This aligns perfectly with the definition of a Proxy Solicitation & Information Statement (PSI).
2020-11-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.